雅思写作题目练习：医药公司应花钱帮贫困人口还是应赚钱

　　雅思写作题目练习：Some people say that drug companies have a responsibility to spend money researching medicines that will help people in poorer countries. Others say the main responsibility of drug companies is to make money.

　　Discuss both views and give your own opinion.

　　雅思写作范文：

　　There are some people who argue that investing money in making medicines beneficial to residents in less-developed nations is something the drug companies ought to be responsible for. Others, however, disagree, claiming that the ultimate goal of these companies is to earn profits. In this essay, both ideas will be analysed before my perspective is given, which is that pharmaceutical corporations should both offer poor people assistance and make money for themselves.

　　It is justified tosee the provision of medicines for people in economically-disadvantaged countries as it can prevent viruses from spreading widely to finally build a better world. If drug companies strive to conduct research and make affordable medicines, inhabitants in deprived areas may not die because they lack sufficient money to buy medicines when suffering from diseases. Thus, viruses will be controlled in a timely manner and not affect other regions of the globe. In other words, people in the entire world can lead a peaceful and healthy life.

　　On the other hand,however, it is the pursuit of economic benefit that is of great importance to drug enterprises because this facilitates their smooth operation. It is widely accepted that the cost of developing new medicines and purchasing equipment is quite high, investors’ benefits have to be considered and employees’ salaries need to be paid on time. With the ability to make money, these organisations would not findit difficult to cover the wide variety of huge expenditure mentioned;otherwise, the existence of these companies could not be expected.

　　In conclusion, both sides of the argument have merit. My firm conviction is that not only should drug companies aid people from poorer countries with medicines in terms of controlling infectious diseases and constructing a healthy world, but also ensure their own benefits to keep themselves running well. Therefore, it is suggested that these companies make reasonable plans to achieve success in both aspects.